Caption Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Caption Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-41,400	Closed	-$4.78M	–	1517
2020 Q4	$4.78M	Buy	+41,400	New	+$4.64M	0.11%	234
2020 Q3	–	Sell	-30,000	Closed	-$3.68M	–	1372
2020 Q2	$3.68M	Buy	+30,000	New	+$3.4M	0.12%	225
2019 Q2	–	Sell	-51,300	Closed	-$8.65M	–	896
2019 Q1	$8.65M	Buy	+51,300	New	+$7.63M	0.48%	50

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Caption Management's GWPH Position: Q1 2020 in Review

Caption Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 38,919 shares — an estimated $4.07M sold.

Caption Management first reported a position in GWPH in Q1 2019 and held it in 3 quarters. The position peaked at $4.07M in Q4 2019. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Caption Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Caption Management sold 38,919 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $4.07M.
Caption Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 3 quarters.
Caption Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4.07M in Q4 2019.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Caption Management's 13F filing for Q1 2020, filed 15 May 2020.